Stay updated on UNCOVER-2: Guselkumab Clinical Trial
Sign up to get notified when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FAuaaFjxvRZ4kdcK2qAC3qEdDCkI.uncropped.jpg&w=3840&q=75)
Latest updates to the UNCOVER-2: Guselkumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has expanded to include 118 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.1%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check18 days agoChange DetectedAn article on the efficacy and safety of switching to Ixekizumab in Etanercept non-responders was published in the American Journal of Clinical Dermatology in April 2017, with an erratum issued in June 2018.SummaryDifference0.1%
- Check25 days agoChange DetectedDifference0.0%
- Check30 days agoChange DetectedDifference0.0%
- Check31 days agoChange DetectedDifference38%
Stay in the know with updates to UNCOVER-2: Guselkumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.